In recent decades, extracellular vesicles (EVs), as bioactive cell-secreted nanoparticles
which are involved in various physiological and pathological processes including cell …

The enormous library of pharmaceutical compounds presents endless research avenues.
However, several factors limit the therapeutic potential of these drugs, such as drug …

Small‐interfering RNA (siRNA) therapy is considered a powerful therapeutic strategy for
treating cardiac hypertrophy, an important risk factor for subsequent cardiac morbidity and …

Noncoding RNAs are closely related to the development of myocardial infarction (MI), and
their specific roles in MI are still being carefully studied. Researchers can select the literature …

Several types of cardiovascular cells use microRNA-21 (miR-21), which has been linked to
cardioprotection. In this study, we systematically reviewed the results of published papers on …

Myocardial infarction (MI) is the most frequent end-point of cardiovascular pathology,
leading to higher mortality worldwide. Due to the particularity of the heart tissue, patients …

The pandemic SARS coronavirus 2 utilizes efficient mechanisms to establish infection and
evade the immune system. Established infection leads to severe inflammation in susceptible …

Cardiovascular diseases (CVD) are the leading cause of morbidity and mortality worldwide.
Conventional therapies involving surgery or pharmacological strategies have shown limited …

Sox4 participates in the progression of embryo development and regulation of apoptosis in
tumors. However, the effect and mechanism of Sox4 in myocardial infarction (MI) remains …